Donaldson Capital Management LLC Sells 74 Shares of Danaher Co. (NYSE:DHR)

Donaldson Capital Management LLC trimmed its position in Danaher Co. (NYSE:DHR) by 5.5% during the third quarter, Holdings Channel reports. The firm owned 1,260 shares of the conglomerate’s stock after selling 74 shares during the quarter. Donaldson Capital Management LLC’s holdings in Danaher were worth $350,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Kanawha Capital Management LLC acquired a new stake in shares of Danaher in the third quarter valued at approximately $217,000. BSW Wealth Partners lifted its holdings in Danaher by 10.3% during the 3rd quarter. BSW Wealth Partners now owns 3,579 shares of the conglomerate’s stock valued at $995,000 after purchasing an additional 334 shares during the last quarter. Nvwm LLC boosted its position in Danaher by 3.9% during the third quarter. Nvwm LLC now owns 5,503 shares of the conglomerate’s stock worth $1,530,000 after purchasing an additional 209 shares during the period. Fort Pitt Capital Group LLC increased its holdings in shares of Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after purchasing an additional 7,421 shares during the last quarter. Finally, Pure Financial Advisors LLC bought a new position in shares of Danaher in the third quarter valued at about $202,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 0.2 %

NYSE DHR opened at $247.18 on Tuesday. Danaher Co. has a fifty-two week low of $192.35 and a fifty-two week high of $281.70. The business has a fifty day moving average price of $266.53 and a two-hundred day moving average price of $260.74. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The stock has a market capitalization of $178.53 billion, a PE ratio of 47.17, a PEG ratio of 4.51 and a beta of 0.85.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.02 earnings per share. Equities analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s dividend payout ratio is currently 20.61%.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 952 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of several research analyst reports. Stephens reaffirmed an “overweight” rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Barclays decreased their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. Evercore ISI lifted their price target on Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. The Goldman Sachs Group upped their price objective on Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Finally, Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a report on Thursday, October 31st. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.